BlackRock’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32B | Buy |
24,001,675
+222,676
| +0.9% | +$12.2M | 0.03% | 530 |
|
2025
Q1 | $1.68B | Buy |
23,778,999
+265,883
| +1% | +$18.8M | 0.04% | 429 |
|
2024
Q4 | $1.55B | Buy |
23,513,116
+889,613
| +4% | +$58.5M | 0.03% | 466 |
|
2024
Q3 | $1.59B | Sell |
22,623,503
-114,846
| -0.5% | -$8.07M | 0.03% | 455 |
|
2024
Q2 | $1.87B | Buy |
22,738,349
+8,259,559
| +57% | +$680M | 0.04% | 377 |
|
2024
Q1 | $1.26B | Sell |
14,478,790
-202,854
| -1% | -$17.7M | 0.03% | 513 |
|
2023
Q4 | $1.42B | Buy |
14,681,644
+74,457
| +0.5% | +$7.18M | 0.04% | 443 |
|
2023
Q3 | $1.29B | Buy |
14,607,187
+591,722
| +4% | +$52.4M | 0.04% | 437 |
|
2023
Q2 | $1.21B | Sell |
14,015,465
-623,111
| -4% | -$54M | 0.03% | 465 |
|
2023
Q1 | $1.42B | Buy |
14,638,576
+98,385
| +0.7% | +$9.57M | 0.04% | 403 |
|
2022
Q4 | $1.5B | Buy |
14,540,191
+252,332
| +2% | +$26.1M | 0.05% | 380 |
|
2022
Q3 | $1.21B | Sell |
14,287,859
-129,242
| -0.9% | -$11M | 0.04% | 422 |
|
2022
Q2 | $1.19B | Buy |
14,417,101
+459,041
| +3% | +$38M | 0.04% | 444 |
|
2022
Q1 | $1.08B | Buy |
13,958,060
+56,879
| +0.4% | +$4.39M | 0.03% | 553 |
|
2021
Q4 | $1.23B | Sell |
13,901,181
-1,419,618
| -9% | -$125M | 0.03% | 518 |
|
2021
Q3 | $1.18B | Buy |
15,320,799
+2,425,231
| +19% | +$187M | 0.03% | 511 |
|
2021
Q2 | $1.08B | Sell |
12,895,568
-1,038,589
| -7% | -$86.7M | 0.03% | 561 |
|
2021
Q1 | $1.05B | Sell |
13,934,157
-780,003
| -5% | -$58.9M | 0.03% | 557 |
|
2020
Q4 | $1.29B | Buy |
14,714,160
+78,638
| +0.5% | +$6.9M | 0.04% | 436 |
|
2020
Q3 | $1.11B | Sell |
14,635,522
-1,328,289
| -8% | -$101M | 0.04% | 418 |
|
2020
Q2 | $1.97B | Buy |
15,963,811
+1,368,101
| +9% | +$169M | 0.08% | 234 |
|
2020
Q1 | $1.23B | Buy |
14,595,710
+1,537,729
| +12% | +$130M | 0.06% | 296 |
|
2019
Q4 | $1.1B | Buy |
13,057,981
+157,268
| +1% | +$13.3M | 0.04% | 426 |
|
2019
Q3 | $870M | Buy |
12,900,713
+40,642
| +0.3% | +$2.74M | 0.04% | 481 |
|
2019
Q2 | $1.1B | Buy |
12,860,071
+196,702
| +2% | +$16.8M | 0.05% | 397 |
|
2019
Q1 | $1.12B | Sell |
12,663,369
-915,193
| -7% | -$81.3M | 0.05% | 374 |
|
2018
Q4 | $1.16B | Sell |
13,578,562
-544,751
| -4% | -$46.4M | 0.06% | 317 |
|
2018
Q3 | $1.37B | Buy |
14,123,313
+1,002,054
| +8% | +$97.2M | 0.06% | 311 |
|
2018
Q2 | $1.24B | Buy |
13,121,259
+323,227
| +3% | +$30.4M | 0.06% | 328 |
|
2018
Q1 | $1.04B | Sell |
12,798,032
-21,712
| -0.2% | -$1.76M | 0.05% | 389 |
|
2017
Q4 | $1.14B | Buy |
12,819,744
+937,183
| +8% | +$83.6M | 0.05% | 348 |
|
2017
Q3 | $1.11B | Buy |
11,882,561
+481,601
| +4% | +$44.8M | 0.06% | 342 |
|
2017
Q2 | $1.04B | Buy |
11,400,960
+335,508
| +3% | +$30.5M | 0.05% | 357 |
|
2017
Q1 | $971M | Buy |
11,065,452
+10,909,162
| +6,980% | +$958M | 0.05% | 362 |
|
2016
Q4 | $12.9M | Buy |
156,290
+8,187
| +6% | +$678K | 0.02% | 663 |
|
2016
Q3 | $13.7M | Buy |
148,103
+10,780
| +8% | +$997K | 0.02% | 639 |
|
2016
Q2 | $10.7M | Sell |
137,323
-18,261
| -12% | -$1.42M | 0.02% | 676 |
|
2016
Q1 | $12.8M | Buy |
155,584
+7,276
| +5% | +$600K | 0.02% | 601 |
|
2015
Q4 | $15.5M | Buy |
148,308
+48,959
| +49% | +$5.13M | 0.02% | 581 |
|
2015
Q3 | $10.5M | Sell |
99,349
-44,498
| -31% | -$4.69M | 0.02% | 615 |
|
2015
Q2 | $19.7M | Sell |
143,847
-129,588
| -47% | -$17.7M | 0.03% | 511 |
|
2015
Q1 | $34.1M | Buy |
273,435
+79,616
| +41% | +$9.92M | 0.05% | 403 |
|
2014
Q4 | $17.5M | Sell |
193,819
-95,557
| -33% | -$8.64M | 0.03% | 558 |
|
2014
Q3 | $20.9M | Sell |
289,376
-19,909
| -6% | -$1.44M | 0.03% | 493 |
|
2014
Q2 | $19.2M | Sell |
309,285
-97,498
| -24% | -$6.07M | 0.03% | 511 |
|
2014
Q1 | $27.7M | Buy |
406,783
+188,063
| +86% | +$12.8M | 0.04% | 424 |
|
2013
Q4 | $15.4M | Buy |
218,720
+136,828
| +167% | +$9.63M | 0.03% | 568 |
|
2013
Q3 | $5.91M | Buy |
81,892
+26,970
| +49% | +$1.95M | 0.01% | 724 |
|
2013
Q2 | $3.06M | Buy |
+54,922
| New | +$3.06M | 0.01% | 832 |
|